Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 709 of 6351
-
New hope for psoriatic arthritis sufferers: experimental drug sonelokimab enters final testing phase
Disease control Recruiting nowThis is a study to confirm the clinical efficacy and safety of sonelokimab compared with placebo in the treatment of adults with active psoriatic arthritis who have had a previous inadequate response or intolerance to anti-tumor necrosis factor (TNF)α therapy.
Phase 3 • Sponsor: MoonLake Immunotherapeutics AG • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New drug sonelokimab aims to ease psoriatic arthritis pain
Disease control OngoingThis is a study to demonstrate the clinical efficacy and safety of sonelokimab administered subcutaneously compared with placebo in the treatment of adult patients with active psoriatic arthritis who are naive to biologic disease-modifying antirheumatic drug therapy.
Phase 3 • Sponsor: MoonLake Immunotherapeutics AG • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New device clears lung clots, eases heart strain in emergency study
Disease control CompletedThis study is a prospective, single-arm, multicenter study to evaluate the safety and effectiveness of the Vertex Pulmonary Embolectomy System in participants presenting with clinical signs and symptoms of acute pulmonary embolism.
Sponsor: Jupiter Endovascular • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Engineered immune cells aim to calm liver scarring in first human trial
Disease control OngoingThe purpose of this study is to assess the safety and efficacy of RTX001 in patients with end-stage liver disease. This study is the first time RTX001, a macrophage cell therapy engineered to have an anti-inflammatory and anti-fibrotic effect, will be given to humans.
Phase 1/2 • Sponsor: Resolution Therapeutics Limited • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Own stem cells could improve movement in kids with cerebral palsy
Disease control Recruiting nowThis clinical trial aims to evaluate the effectiveness of autologous bone marrow mononuclear cell transfusion in treating cerebral palsy caused by cerebral hypoxia. The key questions the study seeks to answer are: * What is the safety profile in terms of adverse events (AE) and…
Phase 2 • Sponsor: Vinmec Research Institute of Stem Cell and Gene Technology • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
School-Based malaria prevention could shield entire villages
Prevention CompletedThis is an individually randomized, controlled, single blind three arm clinical trial of malaria chemoprevention strategies Arm 1: Intermittent preventive treatment with dihydroartemisinin-piperaquine (IPT-DP). Arm 2: Intermittent preventive treatment with sulfadoxine-pyrimethami…
Phase 4 • Sponsor: Liverpool School of Tropical Medicine • Aim: Prevention
Last updated Aug 01, 2026 00:00 UTC
-
New hope for pancreatic cancer: precision drug cocktails under study
Disease control Recruiting nowThe study is being conducted to evaluate the safety, tolerability and efficacy of ADC drugs monotherapy or combination therapy with HRS-4642 or immunotherapy in subjects with locally advanced or metastatic pancreatic cancer.
Phase 2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Immune cells from your own tumor could fight lung cancer
Disease control Recruiting now20 participants are expected to be enrolled for the Phase Ib clinical trial,this trail is expected to be finished in 36 months.
Phase 1 • Sponsor: Shanghai Juncell Therapeutics • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Early heart procedure may cut stroke risk in high-risk AF patients
Disease control Recruiting nowEASThigh-AFNET 11 is an international, prospective, randomized, open, blinded endpoint assessment, multicenter trial (Treatment Strategy trial). The objective of EASThigh-AFNET 11 is to investigate whether early atrial fibrillation ablation in patients with atrial fibrillation (…
Sponsor: Atrial Fibrillation Network • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Sound waves zapping liver tumors: new study tracks Real-World success
Disease control Recruiting nowThe goal of this observational study is to collect information on the use of the HistoSonics Edison System for the treatment of liver tumors. The main aim is to understand how different patient characteristics and procedural characteristics may affect histotripsy success at 36 ho…
Sponsor: HistoSonics, Inc. • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Could a healthy Person's nose bacteria cure sinusitis?
Disease control Recruiting nowChronic rhinosinusitis (CRS) is a disease associated with impaired quality of life and substantial societal costs. Much is still uncertain regarding the underlying etiology of the disease. Current treatment protocols are based on observed effects rather than a mechanistic underst…
Phase 2/3 • Sponsor: Region Skane • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
One shot may shield HIV-Positive women from HPV
Prevention OngoingThe Efficacy of Human Papillomavirus (HPV) Vaccination to Prevent Infection Among Women Living with HIV: A Prospective, Individual, Double-Blind, Randomized Controlled Study is evaluating immediate or delayed single-dose nonavalent HPV vaccination among women living with HIV who …
Phase 4 • Sponsor: Massachusetts General Hospital • Aim: Prevention
Last updated Jun 27, 2026 08:10 UTC
-
Could a simple shot replace IV therapy for tough lymphomas?
Disease control OngoingThe primary purpose of the study is to assess the pharmacokinetics (PK) profile of pembrolizumab following subcutaneous (SC) injection of pembrolizumab coformulated with hyaluronidase, and to evaluate the objective response rate (ORR) of pembrolizumab (+) berahyaluronidase alfa S…
Phase 2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Immunotherapy combo shows promise in hodgkin lymphoma trial
Disease control Recruiting nowPatients in this prospective multicenter phase II study will be randomized between two first-line therapy strategies for advanced stages of cHL. In the Nivo-AVD cohort, patients will receive 2 cycles of nivolumab monotherapy followed by a switch to Nivo-AVD combination therapy (t…
Phase 2 • Sponsor: St. Petersburg State Pavlov Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Anti-Aging drug and football drills join forces to fight brittle bones
Prevention OngoingIt is estimated that women lose around 20-25% of bone mass during the 5-10 years period of postmenopausal transition, and menopause is considered a major risk factor for osteoporotic fragility fracture. Currently, there is no preventive strategy to counteract these changes, and h…
Phase 2 • Sponsor: Odense University Hospital • Aim: Prevention
Last updated Jun 27, 2026 12:04 UTC
-
Could a simple pill tame RSV? new trial tests obeldesivir
Disease control Stopped earlyThe goal of this clinical study was to learn more about the study drug, obeldesivir (ODV; GS-5245), and how safe and effective it was in treating nonhospitalized adults with acute respiratory syncytial virus (RSV) infection. The researchers wanted to see if obeldesivir can help p…
Phase 2 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Can a Nerve-Freezing procedure transform knee replacement recovery?
Symptom relief CompletedTotal Knee Replacement surgery is common procedure that is usually done for patients suffering from persistent pain with limitation of movement. Unfortunately, they do suffer after the operation as it is associated still with significant pain that affect the rehabilitation plan, …
Sponsor: Ain Shams University • Aim: Symptom relief
Last updated Aug 07, 2026 00:00 UTC
-
Spinal implant and robot suit help paralyzed patients take steps
Disease control CompletedSpinal cord injury (SCI) can be caused by trauma, inflammation, tumors, and other factors, often leading to issues such as impaired leg movement, abnormal sensation, and difficulties with bladder and bowel control. These challenges significantly affect the patient's quality of li…
Sponsor: Xuanwu Hospital, Beijing • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Could 3 chemo rounds be enough? new trial aims to cut treatment burden
Disease control Recruiting nowMulticenter, randomized, open label study including patients with advanced HRDpositive high-grade ovarian cancer, fallopian tube cancer, primary peritoneal cancer and clear cell carcinoma of the ovary with no residual tumor mass following primary tumor debulking to determine recu…
Phase 2 • Sponsor: North Eastern German Society of Gynaecological Oncology • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Can genes explain sudden cardiac death in young athletes?
Knowledge-focused Recruiting nowThe increased risk of sudden cardiac arrest (SCA) or sudden cardiac death (SCD) related to vigorous physical activity is well-documented. Currently, for young victims (under 35 years) of SCA/SCD, no etiology is found in 40 to 50% of cases after a standard medical assessment, lead…
Sponsor: Rennes University Hospital • Aim: Knowledge-focused
Last updated Aug 27, 2026 00:00 UTC